Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4,504 | 1 | 95.7% |
| Food and Beverage | $158.68 | 5 | 3.4% |
| Education | $42.00 | 1 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $4,548 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $64.00 | 2 | $0 (2018) |
| Genentech, Inc. | $42.00 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $26.18 | 1 | $0 (2019) |
| UCB, Inc. | $24.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $24.00 | 1 | UCB, Inc. ($24.00) |
| 2019 | $26.18 | 1 | Novartis Pharmaceuticals Corporation ($26.18) |
| 2018 | $4,549 | 2 | Amgen Inc. ($4,504) |
| 2017 | $105.50 | 3 | Amgen Inc. ($44.50) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Immunology | ||||||
| 11/09/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 05/25/2018 | Amgen Inc. | Enbrel (Biological) | — | In-kind items and services | $4,503.88 | Research |
| Study: Subsequent Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment • Category: Inflammation | ||||||
| 11/05/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $44.50 | General |
| Category: Endocrinology | ||||||
| 11/03/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 01/19/2017 | Genentech, Inc. | Actemra (Biological) | Education | In-kind items and services | $42.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Subsequent Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment | Amgen Inc. | $4,504 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 49 | 84 | $33,962 | $5,983 |
| 2022 | 1 | 38 | 67 | $26,637 | $5,363 |
| 2021 | 1 | 37 | 54 | $18,646 | $4,414 |
| 2020 | 2 | 45 | 52 | $16,429 | $3,121 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 49 | 84 | $33,962 | $5,983 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 38 | 67 | $26,637 | $5,363 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 37 | 54 | $18,646 | $4,414 | 23.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 28 | 32 | $10,108 | $1,739 | 17.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 17 | 20 | $6,321 | $1,381 | 21.9% |
About Daniel Solomon, MD MPH
Daniel Solomon, MD MPH is a Internal Medicine healthcare provider based in Brookline, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780634287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Solomon, MD MPH has received a total of $4,705 in payments from pharmaceutical and medical device companies, with $24.00 received in 2022. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "" ($4,504).
As a Medicare-enrolled provider, Solomon has provided services to 169 Medicare beneficiaries, totaling 257 services with total Medicare billing of $18,881. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Brookline, MA
- Active Since 05/12/2006
- Last Updated 01/17/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780634287
Products in Payments
- Enbrel (Biological) $4,504
- Prolia (Biological) $44.50
- Actemra (Biological) $42.00
- COSENTYX (Biological) $26.18
- Cimzia (Drug) $24.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brookline
Sandra Richman, M.d, M.D
Internal Medicine — Payments: $1.3M
Dr. Sarah Grant, Md, MD
Internal Medicine — Payments: $533,460
Dr. Richard Brodie, M.d, M.D
Internal Medicine — Payments: $13,114
Jeremy Nobel, M.d, M.D
Internal Medicine — Payments: $9,606
David Walton, M.d, M.D
Internal Medicine — Payments: $4,039
Lyanne Santana Khoury, Md, MD
Internal Medicine — Payments: $2,836